Product correctly added to cart.

discount label
Lusutrombopag-d13
View 3D

Biosynth logo

Lusutrombopag-d13

CAS: 1110766-97-6

Ref. 3D-KUB76697

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 23 Jul 2024

Product Information

Name:
Lusutrombopag-d13
Description:

Lusutrombopag is a drug that is used for the treatment of chronic liver disease. It belongs to the group of drugs that are inhibitors of P-glycoprotein (Pgp) and are able to increase platelet count in people with chronic liver disease. Lusutrombopag has been shown to be effective in patients with thrombocytopenia, although its long-term efficacy is unknown due to the lack of clinical trials. Lusutrombopag binds to Pgp, which prevents it from transporting substrates such as luteinizing hormone receptor agonists, cytostatics, and immunosuppressants out of cells. This binding leads to increased concentrations of these substances in the blood, which can lead to toxicity. Lusutrombopag has not been associated with any significant toxicity in studies involving humans.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
604.63 g/mol
Formula:
C29H19D13Cl2N2O5S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-KUB76697 Lusutrombopag-d13

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".